LMC Diabetes & Endocrinology Launch Digital Diabetes Platform for 30k Patients

Thought you might find this interesting










Submit

qualcomm medtronic diabetes

LMC Diabetes & Endocrinology (LMC), the largest diabetes specialist care provider in Canada is teaming up with ViiMed to launch a digital diabetes platform for more than 30,000 patients. Delivered via telehealth and remote patient monitoring, the digital diabetes education and management program will expand access to care and help patients self-manage their condition for better outcomes. Providers can foster greater patient engagement and satisfaction, save time, and reduce operational costs using this proactive care delivery approach.

Diabetes affects 415 million people around the world, or roughly one in eleven adults, and is expected to impact 642 million people by 2040. Left unmanaged, diabetes can lead to life-threatening complications such as stroke, heart disease, kidney failure, blindness, and lower limb amputation. Diabetes also carries a huge economic burden, with 12 percent of global health expenditures spent on the condition. When positioned correctly, digital technologies can help individuals with diabetes better manage their condition and lower the risk of complications. They can also improve access to health care and drive efficiencies in care delivery.

 

As part of the partnership, LMC will use ViiMed’s cloud-based platform to educate, coach, and empower patients to adopt healthier behaviors and improve health outcomes. Patients will have access to personalized diabetes management programs that are tailored to meet their unique needs. The platform will allow patients to interact with their diabetes educator and extended care team, participate in educational activities, set measurable goals, track meals and physical activity, and measure key health indicators. By driving long-lasting behavior change amongst individuals, including those in hard-to-reach rural areas, the programs can help reduce risk factors and improve health outcomes for those living with diabetes.

Patients will receive a tailored care plan and have access to their care team from any device through two-way recorded video and text communication, providing a “virtual safety net” for questions or concerns related to their care plan. For clinicians and diabetes educators, the platform will provide greater insight into patients’ progress over time and allow them to intervene, when necessary.

The two companies are also evaluating plans to expand their partnership in areas like diabetes prevention, weight loss, and corporate wellness initiatives. ViiMed integrates with LMC’s electronic health record, Accuro®, for a seamless workflow and reporting stream.

“ViiMed is the best-kept secret in digital health,” said Mark Angelo, CEO of LMC. “After evaluating a number of digital platforms, we selected ViiMed because the technology is flexible enough to grow with us over time and deliver a range of programs, including weight loss, diabetes prevention, and diabetes management. The team there is responsive and agile, and we believe together, we can have an incredible impact on tens of thousands of lives.”